EMEA-001965-PIP01-16
Key facts
Invented name |
|
Active substance |
Olodaterol (hydrochloride)
|
Therapeutic area |
Pneumology-allergology
|
Decision number |
P/0112/2017
|
PIP number |
EMEA-001965-PIP01-16
|
Pharmaceutical form(s) |
Inhalation solution
|
Condition(s) / indication(s) |
Treatment of cystic fibrosis
|
Route(s) of administration |
Inhalation use
|
Contact for public enquiries |
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271 |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|